正文
发布时间
12 分钟前源站更新
12 分钟前首次抓取
12 分钟前发布时间
2026/03/25 04:5812 分钟前源站更新
2026/03/25 04:5812 分钟前首次抓取
2026/03/25 04:5812 分钟前发布时间
12 分钟前源站更新
12 分钟前首次抓取
12 分钟前用于追踪这条内容的来源与记录标识。
Source
原始链接
发布时间
2026/03/25 04:5812 分钟前源站更新
2026/03/25 04:5812 分钟前首次抓取
2026/03/25 04:5812 分钟前发布时间
12 分钟前源站更新
12 分钟前首次抓取
12 分钟前用于追踪这条内容的来源与记录标识。
Source
原始链接
Exclusive: Lilly halts India obesity awareness campaign after regulatory scrutiny, seeks rules clarity
发布时间
150 天前
2026-05-11 19:14:53 UTC
源站更新
150 天前
2026-05-11 19:30:49 UTC
首次抓取
149 天前
2026-05-12 02:49:40 UTC
礼来在印度暂停了肥胖认知宣传活动,因药品监管机构警告该活动可能构成对处方药的间接面向消费者宣传。礼来称活动未提及产品,暂停是出于审慎,并要求监管方进一步明确规则。
Eli Lilly has paused its obesity awareness campaign in India after regulators warned it could amount to indirect advertising of prescription drugs. Lilly says the campaign mentioned no product and is seeking clearer rules on what non-branded, doctor-led awareness efforts are
用于追踪这条内容的来源与记录标识。